Trials / Completed
CompletedNCT03735017
Virtual Reality Walking for Neuropathic Pain in Spinal Cord Injury
Immersive Virtual Walking Treatment for Neuropathic Pain in Spinal Cord Injury
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the effectiveness of one of two virtual reality treatments on neuropathic pain in individuals with spinal cord injury.
Detailed description
The investigators are investigating the effectiveness of one of two possible investigational virtual reality treatments on neuropathic pain in individuals with spinal cord injury. Participants will be randomized to one of these two treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interactive Virtual Reality Walking | Individuals will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart. |
| OTHER | Interactive Virtual Reality Walking | Individuals will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart. |
Timeline
- Start date
- 2018-06-16
- Primary completion
- 2019-07-30
- Completion
- 2019-07-30
- First posted
- 2018-11-08
- Last updated
- 2021-11-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03735017. Inclusion in this directory is not an endorsement.